CDSCO Registration is an important regulatory approval for businesses dealing with healthcare-related products in India. CDSCO stands for Central Drugs Standard Control Organisation, which regulates drugs, medical devices, cosmetics, diagnostics, vaccines, biological products, new drugs, and clinical trial-related products. Any business planning to import, manufacture, sell, stock, distribute, or market such regulated products must first check whether CDSCO registration, licence, permission, or approval is required.
The healthcare sector is strictly regulated because it directly affects human health and public safety. CDSCO approval ensures that only safe, effective, and quality products enter the Indian market. For businesses, it also improves credibility, supports smooth import clearance, and builds trust with hospitals, distributors, doctors, government buyers, and customers. Without proper approval, a business may face shipment detention, product seizure, rejection, licence suspension, penalties, prosecution, or product recall.
Legal Context Governing CDSCO Registration
CDSCO Registration is mainly governed by the Drugs and Cosmetics Act, 1940 and the rules made under it. This Act regulates the import, manufacture, sale, and distribution of drugs and cosmetics in India. It also contains provisions relating to misbranded, adulterated, spurious, and not-of-standard-quality products. The Act empowers the authorities to inspect premises, take samples, seize products, and take legal action in case of non-compliance.
The Drugs Rules, 1945 provide detailed procedures for licensing, manufacturing, sale, testing, storage, labelling, inspection, and distribution of drugs. These rules are relevant for pharmaceutical manufacturers, importers, wholesalers, retailers, and other businesses dealing with drugs. They prescribe the conditions under which licences are issued and maintained.
The Medical Devices Rules, 2017 provide a separate regulatory framework for medical devices in India. These rules classify medical devices into Class A, Class B, Class C, and Class D based on risk. Class A devices are low-risk devices, while Class D devices are high-risk devices. The rules cover import, manufacture, sale, distribution, testing, clinical investigation, quality management systems, and post-market compliance.
The New Drugs and Clinical Trials Rules, 2019 apply to new drugs, investigational new drugs, clinical trials, bioavailability studies, bioequivalence studies, and ethics committee approvals. These rules are important for pharmaceutical companies, research institutions, hospitals, sponsors, and clinical research organizations.
The Cosmetics Rules, 2020 regulate import, manufacture, registration, labelling, and sale of cosmetics in India. These rules apply to skincare products, haircare products, beauty products, makeup products, perfumes, lotions, creams, shampoos, and other personal care products.
Meaning and Scope of CDSCO Registration
CDSCO Registration means the approval, licence, registration certificate, or permission granted by the competent authority for regulated healthcare products. It allows a business to carry out a specific regulated activity such as import, manufacture, sale, stock, distribution, testing, clinical trial, or marketing of covered products in India.
The scope of CDSCO Registration depends on the product category and the nature of activity. For example, an importer of medical devices may require an import licence, while a distributor of medical devices may require sale and distribution registration. A cosmetic importer may require cosmetic import registration, while a company launching a new drug may require prior approval from CDSCO.
It is also important to understand the difference between registration, licence, and permission. Registration may apply to sale, distribution, or product listing activities. A licence is generally required for import or manufacturing activity. Permission is generally required for new drugs, clinical trials, bioavailability studies, bioequivalence studies, and other special approvals. The requirement changes according to the product and business model.
Product category matters because the approval process is not the same for every product. A drug, medical device, cosmetic, diagnostic kit, vaccine, or new drug may follow a different legal route. Therefore, before filing the application, the applicant must identify the correct product category and applicable regulatory route.
Products Covered under CDSCO Registration
CDSCO Registration may apply to drugs and pharmaceutical products. These include medicines used for diagnosis, treatment, mitigation, prevention, or cure of diseases. New formulations, fixed-dose combinations, prescription drugs, imported drugs, and domestically manufactured drugs may require regulatory approval depending on the applicable law.
Medical devices are also covered under CDSCO regulation. These may include instruments, implants, equipment, apparatus, materials, software, or devices used for diagnosis, treatment, monitoring, prevention, or alleviation of disease or injury. Medical devices are regulated based on their risk class under the Medical Devices Rules, 2017.
In-vitro diagnostic devices are also regulated. These include diagnostic kits, reagents, laboratory testing instruments, and products used to examine samples taken from the human body. Since diagnostic results may affect treatment decisions, accuracy, quality, and performance data are important for approval.
Cosmetics and personal care products may also require registration, especially in the case of import. Products such as skincare items, haircare products, beauty products, perfumes, creams, shampoos, and makeup products must comply with the Cosmetics Rules, 2020. Such products should not make medicinal or therapeutic claims unless they are approved under the relevant drug framework.
Vaccines, biological products, new drugs, investigational products, and clinical trial products are also regulated by CDSCO. These products usually require detailed scientific review due to their direct impact on public health and patient safety.
When Is CDSCO Registration Required?
CDSCO Registration is required before importing regulated healthcare products into India. Importers of drugs, medical devices, cosmetics, diagnostics, vaccines, biological products, and other regulated products must obtain the applicable approval before shipment. During customs clearance, authorities may verify whether the importer has a valid CDSCO approval. If approval is missing, the shipment may be detained, delayed, or rejected. CDSCO approval is also required before manufacturing drugs or medical devices in India. A manufacturer cannot legally start production without obtaining the applicable manufacturing licence. Before granting the licence, the authority may examine the premises, equipment, technical staff, quality management system, testing facility, storage conditions, and manufacturing process.
Sale, stock, exhibition, offer for sale, or distribution of medical devices may also require registration. This is relevant for wholesalers, distributors, stockists, traders, and other supply chain entities. In many cases, the application is filed in Form MD-41 and registration is granted in Form MD-42. Cosmetic import also requires registration before the product is brought into India. The importer must submit product details, manufacturer details, ingredient list, labels, authorization documents, and other prescribed documents. The product must comply with Indian cosmetic safety and labelling requirements. CDSCO permission is also required for new drug approval and clinical trials. A company cannot import, manufacture, market, or conduct clinical trials of a new drug without prior approval. The applicant must submit safety, efficacy, quality, scientific, and clinical data as required under the applicable rules.
Product Classification before CDSCO Registration
Product classification is one of the most important steps before applying for CDSCO Registration. The applicant must first identify whether the product is a drug, medical device, cosmetic, in-vitro diagnostic device, vaccine, biological product, or new drug. This classification decides the applicable law, authority, application form, fee, documentation, and approval route.
The intended use of the product plays a major role in classification. If a product is used for diagnosis, treatment, prevention, monitoring, or cure of disease, it may fall under drug or medical device regulation. If it is used for cleansing, beautifying, improving appearance, or personal care, it may fall under cosmetic regulation. Therefore, product labels, claims, ingredients, brochures, website content, and marketing material should be reviewed carefully. Medical devices are classified into Class A, Class B, Class C, and Class D based on risk. Class A devices are low-risk devices, Class B devices are low-to-moderate risk devices, Class C devices are moderate-to-high risk devices, and Class D devices are high-risk devices. Higher-risk devices usually require deeper review, stronger documentation, and stricter post-market monitoring.
In-vitro diagnostic devices are classified based on individual risk and public health risk. These devices include diagnostic kits, reagents, laboratory instruments, and testing products used to examine human samples. Since these results may influence medical decisions, performance and accuracy data are important. Wrong classification may result in wrong form filing, repeated CDSCO queries, delay in approval, rejection, or re-filing of the application. Therefore, the applicant should check the latest classification list and applicable rules before starting the registration process.
Types of CDSCO Registration and Licences
1. Medical Device Import Licence
A medical device import licence is required when a business wants to import medical devices into India from a foreign manufacturer. The application is generally filed by the Indian authorized agent or importer. Form MD-14 is used for application, and Form MD-15 is issued as the import licence after approval.
2. Medical Device Manufacturing Licence
A medical device manufacturing licence is required when a company wants to manufacture medical devices in India. The licence requirement depends on the risk class of the device. The manufacturer must have proper premises, machinery, trained staff, quality management system, testing arrangements, storage facilities, and records as per applicable rules.
3. Sale and Distribution Registration
Sale and distribution registration is required for businesses involved in selling, stocking, exhibiting, offering for sale, or distributing medical devices. This registration applies to wholesalers, distributors, stockists, and traders. The application is generally filed in Form MD-41, and the registration certificate is issued in Form MD-42 after approval.
4. Cosmetic Import Registration
Cosmetic import registration is required before importing cosmetic products into India. It covers product variants, pack sizes, manufacturer details, ingredients, labels, and manufacturing premises. The importer must ensure that the cosmetic product follows Indian safety, labelling, and ingredient requirements before placing it in the Indian market.
5. New Drug Approval
New drug approval is required before launching a new drug in India. A new drug may include a new molecule, formulation, indication, dosage form, strength, route of administration, or fixed-dose combination. CDSCO reviews safety, efficacy, quality, stability data, clinical data, and manufacturing details before granting approval.
6. Clinical Trial Permission
Clinical trial permission is required before starting any clinical trial in India. The applicant must submit the trial protocol, ethics committee approval, informed consent documents, investigator details, safety data, and scientific information. This approval ensures that the trial is conducted ethically and that participant safety is properly protected.
Process to Get CDSCO Registration in India
Step 1: Identify the Product Category
The first step is to identify whether the product is a drug, medical device, cosmetic, diagnostic device, vaccine, biological product, or new drug. This step is important because every product category follows a different legal route, application process, authority, documentation requirement, and approval timeline under CDSCO regulations.
Step 2: Check Whether CDSCO Approval Is Applicable
After identifying the product, the applicant must check whether CDSCO approval is required. Some products may look like ordinary consumer goods, but due to their medical use, ingredients, claims, or diagnostic function, they may fall under CDSCO regulation. This check helps avoid wrong filing and compliance issues.
Step 3: Determine the Type of Applicant
The applicant must identify whether they are a manufacturer, importer, Indian authorized agent, distributor, wholesaler, stockist, or marketer. This is important because the application route changes according to the applicant type. For imported products, a foreign manufacturer usually appoints an Indian authorized agent for filing and communication.
Step 4: Classify the Product Correctly
Correct product classification is necessary before filing the application. Medical devices must be classified as Class A, B, C, or D based on risk. Cosmetics, drugs, diagnostics, and new drugs also require proper classification. Wrong classification may lead to CDSCO queries, wrong form selection, delay, or rejection.
Step 5: Select the Correct CDSCO Application Form
The applicant must select the correct form according to the product and activity. For medical device import, Form MD-14 is used and Form MD-15 is issued. For sale and distribution, Form MD-41 is used and Form MD-42 is issued. Wrong form selection may delay approval.
Step 6: Create Login on CDSCO or SUGAM Portal
Most CDSCO applications are filed online through the CDSCO or SUGAM portal. The applicant must create a login, enter company details, contact details, address, and upload authorization documents. Profile verification is generally required before filing the final application, so all details must be correct and consistent.
Step 7: Prepare the Required Documents
The applicant must prepare all required documents before filing. These may include business registration proof, product technical documents, quality certificates, test reports, labels, safety data, authorization documents, and fee receipt. All documents should be valid, clear, signed, stamped, and consistent to avoid CDSCO queries or rejection.
Step 8: Pay the Applicable Government Fee
The government fee depends on the product category, risk class, application type, number of products, number of manufacturing sites, and licence type. The applicant must pay the fee through the prescribed mode and upload the payment proof with the application. Incorrect fee payment may lead to queries.
Step 9: Submit the Online Application
After preparing documents and paying the fee, the applicant must submit the online application through the CDSCO portal. Product name, model number, manufacturer details, intended use, classification, certificate details, and label information must match across all documents. Any mismatch may result in clarification or delay.
Step 10: Respond to CDSCO Queries
CDSCO may raise queries if any document is missing, expired, unclear, inconsistent, or technically insufficient. The applicant must respond within the prescribed timeline with proper explanation and supporting documents. A clear, point-wise, and well-supported reply helps move the application forward and reduces chances of rejection.
Step 11: Complete Inspection, Audit, or Technical Review
Some applications may require inspection, audit, technical review, testing, or expert evaluation. This is common in manufacturing licences, high-risk medical devices, new drugs, and clinical trial approvals. The applicant must cooperate with the authority and provide required documents, site access, clarifications, and corrective actions where needed.
Step 12: Obtain Registration, Licence, or Permission
Once the authority is satisfied with the application, documents, inspection, and technical review, it grants the registration, licence, or permission. After approval, the applicant can carry out only the approved activity for approved products, models, sites, and purposes as mentioned in the licence or certificate.
Step 13: Follow Post-Registration Compliance Requirements
CDSCO compliance does not end after approval. The licence holder must maintain records, follow labelling rules, ensure quality control, monitor product performance, report adverse events, respond to complaints, and obtain approval or give intimation for changes. Regular compliance helps avoid suspension, cancellation, seizure, penalties, or recall.
Documents Required for CDSCO Registration
The documents required for CDSCO Registration depend on the product category, applicant type, and approval route. However, some documents are commonly required in most applications. Business registration documents are required to prove the legal identity of the applicant. These may include certificate of incorporation, partnership deed, LLP agreement, PAN, GST registration, Import Export Code, registered office proof, board resolution, and authorization letter. Authorized agent documents are required when a foreign manufacturer appoints an Indian entity to act on its behalf. These may include power of attorney, undertaking, wholesale licence where applicable, responsibility declaration, and business authorization documents.
Product technical documents are required to explain the product in detail. These may include product description, intended use, specifications, design details, material details, working principle, safety information, performance data, and applicable standards. Quality management certificates are required to show that the manufacturer follows proper quality systems. For medical devices, ISO 13485 certification is commonly required. Other GMP-related documents or quality system certificates may also be required depending on the product.
The device master file is one of the most important technical documents for medical device approval. It includes device design, description, intended use, raw materials, manufacturing process, risk analysis, safety data, performance data, labelling, packaging, and clinical evaluation where applicable. The plant master file contains details of the manufacturing site. It includes manufacturing site details, layout, equipment, technical staff, quality control facility, utilities, storage area, validation systems, and environmental controls.
A free sale certificate may be required for imported products. It proves that the product is freely sold in the country of origin or another regulated market. The certificate should be issued by a competent authority and should be valid at the time of filing. A manufacturing licence from the country of origin may also be required for imported products. It proves that the foreign manufacturer is legally permitted to manufacture the product and that the licence covers the relevant product and manufacturing site.
Labels and packaging details must comply with Indian rules. Labels should contain product name, manufacturer details, importer details, batch number, manufacturing date, expiry date, licence number, storage conditions, warnings, and instructions for use. Test reports and safety data may be required depending on the product. These may include stability data, performance reports, electrical safety reports, clinical evaluation, toxicology data, biological evaluation, sterilization validation, or other safety documents.
CDSCO Registration for Medical Devices
Medical device registration in India mainly depends on the risk class of the device and the business activity involved. Class A medical devices are low-risk devices. These devices usually have simpler documentation requirements, but they must still comply with applicable safety, quality, and labelling rules. Class B medical devices are low-to-moderate risk devices. These devices require more technical documents and regulatory review compared to Class A devices. Quality certification and proper product documentation are important for approval.
Class C medical devices are moderate-to-high risk devices. These products may directly affect patient health and safety. Therefore, they require detailed technical review, performance data, safety information, and strong quality system documents. Class D medical devices are high-risk devices. These may include life-supporting, implantable, or critical-use devices. Since failure can cause serious harm, these devices require strict regulatory review and strong post-market monitoring.
An import licence for medical devices is required before importing devices into India. The Indian authorized agent applies to CDSCO and submits foreign manufacturer documents, product details, quality certificates, free sale certificate, and authorization documents. Only approved models can be imported. A manufacturing licence for medical devices is required for Indian production. The premises must be suitable for manufacturing and must have trained technical staff, equipment, testing arrangements, and quality systems. Inspection may be conducted before approval. Form MD-42 registration is required for entities that sell, stock, exhibit, offer for sale, or distribute medical devices. It is generally obtained after filing Form MD-41. This registration is important for wholesalers and distributors.
Important CDSCO Forms
Several forms are used under the Medical Devices Rules and other CDSCO regulations. Selecting the correct form is important because the wrong form may delay or invalidate the application. Form MD-14 is used for applying for an import licence for medical devices. It is filed by the importer or Indian authorized agent and includes product details, manufacturer details, manufacturing site details, classification, intended use, and supporting documents.
Form MD-15 is the import licence issued by CDSCO after approval of Form MD-14. It allows the approved medical devices to be imported into India subject to the conditions mentioned in the licence. Form MD-41 is the application form for registration to sell, stock, exhibit, offer for sale, or distribute medical devices. It is generally used by wholesalers, distributors, stockists, and traders.
Form MD-42 is the registration certificate issued after approval of Form MD-41. It allows the applicant to legally sell, stock, exhibit, offer for sale, or distribute medical devices in India.
Manufacturing licence forms depend on the device class and type of manufacturing activity. Separate forms may apply for manufacturing licences, loan licences, test licences, and other permissions. Clinical trial and new drug approval forms are used for new drug permission, clinical trial approval, bioavailability studies, bioequivalence studies, and clinical investigation of medical devices. These applications require scientific data and ethics committee approval where applicable.
Post-Registration Compliance Requirements
After obtaining CDSCO Registration, the licence holder must follow all approval terms. The business can market only approved products and must maintain valid documents. Renewals, updates, and changes must be handled as per the applicable rules. Labelling compliance is a key post-registration requirement. The label must contain correct product information, mandatory declarations, importer details where applicable, and proper warnings or instructions.
It must not contain false, misleading, or unapproved claims. Quality management system compliance ensures that products continue to meet approved standards. Manufacturers must maintain quality systems, follow approved manufacturing processes, keep production and testing records, and conduct regular quality checks.
Record maintenance is also necessary. The licence holder must maintain import records, sale records, distribution records, complaint records, recall records, adverse event records, and quality control records. These records may be inspected by regulatory authorities.Post-market surveillance means monitoring the product after it is placed in the market. The licence holder must track complaints, investigate defects, monitor product performance, and take corrective action whenever required.
Adverse event reporting is required when a serious incident, device malfunction, injury, or unexpected risk is reported. The licence holder must maintain incident records and cooperate with the regulatory authority.Change approval or intimation may be required if there is any change in manufacturer, manufacturing site, label, product design, intended use, authorized agent, or quality system. Some changes may require prior approval before implementation.
Legal Penalties of Non-Compliance
Non-compliance with CDSCO requirements can lead to serious legal and business consequences. If the licence holder violates the rules, the authority may suspend the licence. During suspension, the business activity may stop and corrective action may be required. Serious violations may lead to cancellation of registration or licence. Once cancelled, the product cannot be legally marketed. The applicant may have to re-apply after correcting all issues, and legal action may also follow. Product seizure may happen when non-compliant products are found during inspection. Regulatory officers may seize stock, examine records, and stop sale or distribution of the product.
Import detention may happen if the shipment does not have valid CDSCO approval or if the imported product does not match the approved licence. This may cause delay, financial loss, and supply chain disruption. Penalties under applicable law may include fine, prosecution, or imprisonment depending on the seriousness of the violation. Since healthcare products affect public health, non-compliance is treated seriously. Product recall may be required if a product is found unsafe, defective, misbranded, or not of standard quality. The company may need to withdraw the product from the market, inform distributors and customers, take corrective action, and report to the authority.
Common Reasons for CDSCO Application Rejection
CDSCO applications may be delayed or rejected if they are not properly prepared. Wrong product classification is one of the most common reasons for rejection. If the applicant selects the wrong risk class, wrong product category, wrong authority, or wrong approval route, CDSCO may raise objections. Incomplete documentation may also delay or weaken the application. Missing certificates, unsigned documents, poor-quality scans, incomplete technical files, or missing authorization documents can result in queries.
Expired certificates are another common issue. ISO certificates, free sale certificates, manufacturing licences, and authorization documents must be valid at the time of submission. Incorrect labelling may lead to objections. Labels must include importer details, batch number, expiry details, warnings, instructions, and other mandatory information. Claims must comply with Indian rules. Mismatch in product details can create problems. Product names, model numbers, manufacturer addresses, certificate details, and specifications must be consistent across all documents.
Wrong form selection may result in delay or rejection. CDSCO has different forms for import, manufacture, sale, distribution, testing, clinical investigation, and new drug approval. The applicant must choose the correct form. Inadequate technical data can lead to queries, especially for high-risk devices, diagnostics, and new drugs. Safety data, performance data, risk analysis, clinical evaluation, and test reports must be properly submitted. Poor response to CDSCO queries may also result in rejection. The applicant must answer each query clearly, attach supporting documents, and submit the reply within the timeline. Delayed or unclear replies may increase the risk of rejection.
Recent Updates in CDSCO Registration
CDSCO has increased its focus on stronger regulation of medical devices, risk-based control, quality monitoring, and market surveillance. Medical device businesses must now pay greater attention to classification, documentation, quality systems, and post-market duties. Online filing through CDSCO portals has made the application process more organized. Applicants can file applications, upload documents, pay fees, track status, and respond to queries online. However, online filing also requires accuracy and consistency in documents.
Updated medical device classification is important for applicants. Since classification decides the approval route, businesses should check the latest classification list before filing. Old classification data may lead to wrong filing. Sampling and testing guidelines are important for product safety monitoring. Authorities may collect samples from the market and test them to verify quality. If samples fail, action may be taken against the licence holder. Export and market standing certificates may be required by businesses involved in export or international regulatory submissions. CDSCO may issue market standing certificates, non-conviction certificates, and other export support documents as per applicable procedure.
Draft amendments and new circulars show that CDSCO compliance is continuously developing. Businesses must regularly monitor legal updates, changes in forms, and procedural requirements to remain compliant.
Timeline for CDSCO Registration
The timeline for CDSCO Registration depends on the product category. Drugs, medical devices, cosmetics, diagnostics, new drugs, and clinical trial applications may all have different timelines. A simple registration may take less time, while a high-risk product may take longer. Risk classification also affects the timeline. Class A devices may be processed faster, while Class C and Class D devices may require detailed technical review and stricter evaluation. Document completeness plays a major role in approval speed. Complete documents, valid certificates, clear labels, and consistent details help reduce queries and delays.
Query response time also affects the final timeline. Quick and proper replies help the application move forward. Weak replies, delayed responses, or repeated queries can increase the total time. Inspection or expert review may increase the timeline. Site inspection, technical review, expert committee evaluation, and testing may be required in certain cases, especially for manufacturing licences and high-risk products.
Practical Tips for Smooth CDSCO Registration
Applicants should conduct proper product classification before filing the application. This helps in selecting the correct form, authority, fee, and documents. Wrong classification can delay the entire approval process. All documents should be valid and consistent. Product name, model number, manufacturer address, certificate number, label details, and intended use must match across all documents. Even small differences may result in queries.
The applicant should select the correct form and authority. A wrong form or wrong submission route can lead to unnecessary delay or rejection. The applicant should review applicable rules before filing. A strong technical file should be prepared. For medical devices, the device master file, plant master file, risk analysis, safety data, performance data, specifications, and product labels should be properly prepared.
Query replies should be clear, complete, and supported by evidence. A short or vague reply may not satisfy the authority. Each query should be answered point-wise with supporting documents. Businesses should also track recent CDSCO updates, circulars, notices, and amendments. Regulatory requirements may change, especially in the medical device and cosmetics sectors. Staying updated helps avoid non-compliance.
Conclusion
CDSCO Registration is an important legal requirement for businesses planning to enter the Indian healthcare market. It is required before carrying out regulated activities such as import, manufacture, sale, distribution, or clinical research of drugs, medical devices, cosmetics, diagnostics, new drugs, and other covered products. The registration process helps ensure that products placed in the market are safe, effective, properly labelled, and of standard quality.
CDSCO approval also improves business credibility and supports smoother market entry, import clearance, and compliance confidence. However, obtaining approval is only the first step. Businesses must continue to maintain records, follow quality standards, report adverse events, monitor product performance, and stay updated with legal changes. For professional assistance with CDSCO Registration and related compliance, you can contact Compliance Calendar LLP at info@ccoffice.in or call 9988424211.
Frequently Asked Questions (FAQs)
Q1. What is CDSCO Registration?
Ans. CDSCO Registration is a regulatory approval required for drugs, medical devices, cosmetics, diagnostics, new drugs, and other regulated healthcare products before they are imported, manufactured, sold, or distributed in India.
Q2. Who grants CDSCO Registration in India?
Ans. CDSCO Registration is granted by the Central Drugs Standard Control Organisation or the concerned licensing authority, depending on the product category and type of activity.
Q3. Is CDSCO Registration mandatory for medical devices?
Ans. Yes, medical devices covered under the Medical Devices Rules, 2017 require applicable registration, licence, or approval based on their risk class and business activity.
Q4. Which form is used for medical device import licence?
Ans. For medical device import, the application is generally filed in Form MD-14, and the import licence is generally issued in Form MD-15.
Q5. What is Form MD-42?
Ans. Form MD-42 is the registration certificate for sale, stock, exhibit, offer for sale, or distribution of medical devices. The application is generally filed in Form MD-41.
Q6. Is CDSCO approval required for importing cosmetics?
Ans. Yes, cosmetic import requires registration under the Cosmetics Rules, 2020 before the products are imported into India.
Q7. What is the role of an Indian authorized agent?
Ans. An Indian authorized agent represents a foreign manufacturer before CDSCO and is responsible for filing applications, communication, and regulatory compliance in India.
Q8. Why is product classification important in CDSCO Registration?
Ans. Product classification decides the applicable law, form, authority, fee, documents, and approval route. Wrong classification may lead to delay or rejection.
Q9. What are common reasons for CDSCO application rejection?
Ans. Common reasons include wrong classification, incomplete documents, expired certificates, incorrect labelling, mismatch in product details, wrong form selection, and weak query replies.
Q10. Does CDSCO compliance end after approval?
Ans. No, CDSCO compliance does not end after approval. The licence holder must continue to follow labelling rules, quality standards, record maintenance, post-market surveillance, adverse event reporting, and change approval requirements.
Author Bio
